Even as early as this summer, people began to have some hope or at least cautious optimism that the pandemic would fade into the background, new mutations of the COVID-19 virus may bring it back, and it could be even stronger.
Delta, a highly contagious SARS-CoV-2 virus strain first identified in India in December, is a serious concern right now. It spread quickly throughout that country and Great Britain before making its way to the United States, where it is today the most common variation.
The Centers for Disease Control and Prevention (CDC) described Delta as more transmissible than the common cold and influenza, as well as the viruses that cause smallpox, MERS, SARS, and Ebola.
From what we know so far, people who are fully vaccinated against the coronavirus continue to have strong protection against COVID-19 compared to those who aren’t. Doctors warn that anyone who hasn’t been vaccinated and isn’t using preventive measures is at high risk of contracting the new variant.
Here are five things you should know about the Delta variant:
1. Delta is more contagious than the other virus strains.
One thing that is unique about Delta is how quickly it is spreading, says F. Perry Wilson, MD, a Yale Medicine epidemiologist. Around the world, he says, “Delta will certainly accelerate the pandemic.” The first Delta case was identified in December 2020, and the variant soon became the predominant strain of the virus in both India and then Great Britain. By the end of July, Delta was the cause of more than 80% of new U.S. COVID-19 cases, according to CDC estimates.
A July CDC report on Delta’s transmissibility came after an outbreak that occurred in Provincetown, Mass., after a crowded July 4 weekend, which quickly turned into a cluster of at least 470 cases. While the number of reported “breakthrough” cases, in general, has been very low in the U.S., three-quarters of those infected in Provincetown were people who had been immunized. According to the CDC, even people with breakthrough cases carry tremendous amounts of virus in their nose and throat, and, according to preliminary reports, can spread the virus to others whether or not they have symptoms.
The CDC has labeled Delta “a variant of concern,” using a designation also given to the Alpha strain that first appeared in Great Britain, the Beta strain that first surfaced in South Africa, and the Gamma strain identified in Brazil. (The new naming conventions for the variants were established by the World Health Organization [WHO] as an alternative to numerical names.)
“It’s actually quite dramatic how the growth rate will change,” says Dr. Wilson, commenting on Delta’s spread in the U.S. in June. Delta was spreading 50% faster than Alpha, which was 50% more contagious than the original strain of SARS-CoV-2, he says. “In a completely unmitigated environment—where no one is vaccinated or wearing masks—it’s estimated that the average person infected with the original coronavirus strain will infect 2.5 other people,” Dr. Wilson says. “In the same environment, Delta would spread from one person to maybe 3.5 or 4 other people.”
“Because of the math, it grows exponentially and more quickly,” he says. “So, what seems like a fairly modest rate of infectivity can cause a virus to dominate very quickly.”
2. Unvaccinated people are at risk.
People who have not been fully vaccinated against COVID-19 are most at risk.
In the U.S., there is a disproportionate number of unvaccinated people in Southern and Appalachian states including Alabama, Arkansas, Georgia, Mississippi, Missouri, and West Virginia, where vaccination rates are low. (In some of these states, the number of cases is on the rise even as some other states are lifting restrictions because their cases are going down).
Kids and young people are a concern as well. “A recent study from the United Kingdom showed that children and adults under 50 were 2.5 times more likely to become infected with Delta,” says Dr. Yildirim. And so far, no vaccine has been approved for children 5 to 12 in the U.S., although the U.S. and a number of other countries have either authorized vaccines for adolescents and young children or are considering them.
“As older age groups get vaccinated, those who are younger and unvaccinated will be at higher risk of getting COVID-19 with any variant,” says Dr. Yildirim. “But Delta seems to be impacting younger age groups more than previous variants.”
3. Delta could lead to ‘hyperlocal outbreaks.’
If Delta continues to move fast enough to accelerate the pandemic, Dr. Wilson says the biggest questions will be about the heightened transmissibility—how many people will get the Delta variant and how fast will it spread?
The answers could depend, in part, on where you live—and how many people in your location are vaccinated, he says. “I call it ‘patchwork vaccination,’ where you have these pockets that are highly vaccinated that are adjacent to places that have 20% vaccination,” Dr. Wilson says. “The problem is that this allows the virus to hop, skip, and jump from one poorly vaccinated area to another.”
In some cases, a low-vaccination town that is surrounded by high vaccination areas could end up with the virus contained within its borders, and the result could be “hyperlocal outbreaks,” he says. “Then, the pandemic could look different than what we’ve seen before, where there are real hotspots around the country.”
Some experts say the U.S. is in a good position because of its relatively high vaccination rates—or that conquering Delta will take a race between vaccination rates and the variant. But if Delta keeps moving fast, multiplying infections in the U.S. could steepen an upward COVID-19 curve, Dr. Wilson says.
- RELATED: South African researchers keep close eyes on yet another new coronavirus variant
- RELATED: COVID-19: After a nine-month closure, the Eiffel Tower to reopen
So, instead of a three- or four-year pandemic that peters out once, enough people are vaccinated, an uptick in cases would be compressed into a shorter period of time. “That sounds almost like a good thing,” Dr. Wilson says. “It’s not.” If too many people are infected at once in a particular area, the local health care system will become overwhelmed, and more people will die, he says. While that might be less likely to happen in the U.S., it will be the case in other parts of the world, he adds. “That’s something we have to worry about a lot.”
4. There is still more to learn about Delta.
One important question is whether the Delta strain will make you sicker than the original virus. But many scientists say they don’t know yet. Early information about the severity of Delta included a study from Scotland that showed the Delta variant was about twice as likely as Alpha to result in hospitalization in unvaccinated individuals, but other data has shown no significant difference.
Another question focuses on how Delta affects the body. There have been reports of symptoms that are different than those associated with the original coronavirus strain, Dr. Yildirim says. “It seems like cough and loss of smell are less common. And headache, sore throat, runny nose, and fever are present based on the most recent surveys in the U.K., where more than 90% of the cases are due to the Delta strain,” she says.
Experts are starting to learn more about Delta and breakthrough cases. A Public Health England analysis (in a preprint that has not yet been peer-reviewed) showed at least two vaccines to be effective against Delta. The Pfizer-BioNTech vaccine was 88% effective against symptomatic disease and 96% effective against hospitalization from Delta in the studies, while Oxford-AstraZeneca (which is not an mRNA vaccine and is not yet available in the U.S.) was 60% effective against symptomatic disease and 93% effective against hospitalization. The studies tracked participants who were fully vaccinated with both recommended doses.
Moderna also reported on studies (not yet peer-reviewed) that showed its vaccine to be effective against Delta and several other mutations (researchers noted only a “modest reduction in neutralizing titers” against Delta when compared to its effectiveness against the original virus).
“So, your risk is significantly lower than someone who has not been vaccinated and you are safer than you were before you got your vaccines,” Dr. Yildirim says.
But in August, the Biden administration said that, pending FDA clearance, it will offer all Americans who are fully vaccinated with the mRNA vaccines booster shots, and that could start as soon as late September. While there still needs to be an FDA determination that boosters will be safe and effective, officials recommended them as soon as September 20. They based their advisory on the spread of Delta and three recent studies from the CDC that suggested vaccine protection against infection is waning. In one of those studies, data from the state of New York showed vaccine effectiveness dropping from 91.7 to 79.8% against infection, although the vaccine continued to protect against hospitalization.
Earlier this summer, Johnson & Johnson reported that its vaccine is effective against Delta, but another study suggested that its vaccine may be less effective against the variant, which prompted discussion over whether J&J recipients might also need a booster. In August, the company announced that new data showed a booster shot at six months had a rapid and robust nine-fold increase in spike-binding antibodies in volunteers compared to 28 days after their first dose. That data has not yet been peer-reviewed or published in a scientific journal.
There are additional questions and concerns about Delta, including Delta Plus—a subvariant of Delta, that has been found in the U.S., the U.K., and other countries. “Delta Plus has one additional mutation to what the Delta variant has,” says Dr. Yildirim. This mutation, called K417N, affects the spike protein that the virus needs to infect cells, and that is the main target for the mRNA and other vaccines, she says.
“Delta Plus has been reported first in India, but the type of mutation was reported invariants such as Beta that emerged earlier. More data is needed to determine the actual rate of spread and impact of this new variant on disease burden and outcome,” Dr. Yildirim adds.
5. Vaccination is the best protection against Delta.
The most important thing you can do to protect yourself from Delta is to get fully vaccinated, the doctors say. At this point, that means if you get a two-dose vaccine-like Pfizer or Moderna, for example, you must get both shots and then wait the recommended two-week period for those shots to take full effect. Whether or not you are vaccinated, it’s also important to follow CDC prevention guidelines that are available for vaccinated and unvaccinated people.
“Like everything in life, this is an ongoing risk assessment,” says Dr. Yildirim. “If it is sunny and you’ll be outdoors, you put on sunscreen. If you are in a crowded gathering, potentially with unvaccinated people, you put your mask on and keep social distancing. If you are unvaccinated and eligible for the vaccine, the best thing you can do is to get vaccinated.”
Face masks can provide additional protection and the WHO has encouraged mask-wearing even among vaccinated people. The CDC updated its guidance in July to recommend that both vaccinated and unvaccinated individuals wear masks in public indoor settings in areas of high transmission to help prevent Delta’s spread and to protect others, especially those who are immuno-compromised, unvaccinated, or at risk for severe disease. The agency is also recommending universal indoor masking for all teachers, staff, students, and visitors to K-12 schools.
Of course, there are many people who cannot get the vaccine, because their doctor has advised them against it for health reasons or because personal logistics or difficulties have created roadblocks—or they may choose not to get it. Will the Delta variant be enough to encourage those who can get vaccinated to do so? No one knows for sure, but it’s possible, says Dr. Wilson, who encourages anyone who has questions about vaccination to talk to their family doctor.
“When there are local outbreaks, vaccine rates go up,” Dr. Wilson says. “We know that if someone you know gets really sick and goes to the hospital, it can change your risk calculus a little bit. That could start happening more. I’m hopeful we see vaccine rates go up.”
BBNaija season 7: Fans reacts as Biggie’s reveals the “fake housemate”
Wife of singer, Ne-Yo announces marriage crash
BBNaija Season 7: Chomzy says she will snatch Groovy from Beauty
BBNaija season 7: Level Up eviction night, strike, new and fake housemates
BBNaija season 7: Twitter users respond to the show’s first Saturday night party.
Barcelona activate €100m lever to register new players
Risks of consuming too much ginger
Bella Shmurda reveals why people engage in fraud.
Shehu Sani Slams Government Over Call To Fire Employees Over 50 years.
BBNaija season 7: Big Brother might be swapping housemates today.
Kizz Daniel arrested in Tanzania for not performing at his concert.
Ik Ogbonna says men should look beyond pretty faces and nice shape when dating.
Toyin Lawani reveals how her uncle impregnated her at a tender age.
2023 Presidency: Yoruba Elders claim Tinubu will be the next president.
2033 Presidency: Atiku Group tells Keyamo that Tinubu is a poor product.
BBNaija Season 7: Groovy comments on Beauty’s disqualification.
Join us on Facebook
Health4 days ago
Risks of consuming too much ginger
Entertainment4 days ago
BBNaija season 7: Love triangle as Groovy confesses feelings for Beauty and Ilebaye
Entertainment3 days ago
Wizkid admits he once risk his school fees on table tennis.
News4 days ago
Suspect sentenced to death for murder of Akwa Ibom job seeker
News3 days ago
Two people killed by lightning strike near White House
Politics3 days ago
Bauchi senator emerges as NNPP governorship candidate
Entertainment3 days ago
BBNaija Season 7: Beauty tells Groovy to see her parents if he wants her.
News5 days ago
NBC fines DSTV, Trust TV, others N5m each over documentary on bandits